Person

George Fennell

Executive Vice President, Idexx Laboratories

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$16.7M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 10, 2026IDXXSale1,130$643.00$727K
Feb 10, 2026IDXXSale397$644.02$256K
Feb 10, 2026IDXXSale2,161$645.25$1.4M
Feb 10, 2026IDXXSale1,060$647.21$686K
Feb 10, 2026IDXXSale966$648.78$627K
Feb 10, 2026IDXXSale2,809$649.26$1.8M
Feb 10, 2026IDXXSale40$650.32$26K
Feb 10, 2026IDXXSale2,782$646.23$1.8M
Feb 10, 2025IDXXSale9,986$462.53$4.6M
Feb 8, 2024IDXXSale412$575.80$237K
Feb 8, 2024IDXXSale1,125$573.98$646K
Feb 8, 2024IDXXSale2,279$572.78$1.3M
Feb 8, 2024IDXXSale1,209$572.14$692K
Feb 8, 2024IDXXSale3,173$575.02$1.8M

SEC reporting-owner ID (CIK) 1521861 · all filings on EDGAR